Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Infergen (Beijing) Biotechnology is a specialized biotechnology company focused on the development, manufacturing, and commercialization of advanced molecular diagnostic products. Headquartered in Beijing, the company leverages high-throughput sequencing and quantitative PCR technologies to provide precise solutions for infectious disease screening, oncology diagnostics, and personalized medicine. Infergen's extensive portfolio includes diagnostic kits for pathogens such as human papillomavirus (HPV), viral hepatitis, and various respiratory viruses, many of which are widely utilized in clinical settings across China. By integrating innovative biotechnology with robust bioinformatics, the company delivers high-quality, accessible diagnostic tools that support early disease detection and informed clinical decision-making.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Infergen.